Santarus patents expiration
1. Magnesium Hydroxide And Omeprazole And Sodium Bicarbonate patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6489346 | SANTARUS | Substituted benzimidazole dosage forms and method of using same |
Jul, 2016
(7 years ago) | |
| US7399772 | SANTARUS | Substituted benzimidazole dosage forms and method of using same |
Jul, 2016
(7 years ago) | |
| US6645988 | SANTARUS | Substituted benzimidazole dosage forms and method of using same |
Jul, 2016
(7 years ago) | |
| US6699885 | SANTARUS | Substituted benzimidazole dosage forms and methods of using same |
Jul, 2016
(7 years ago) | |
Drugs and Companies using MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM BICARBONATE ingredient
Market Authorisation Date: 04 December, 2009
Treatment: Short-term treatment of active duodenal ulcer; Treatment of heartburn and other symptoms associated with gerd; Short-term treatment of erosive esophagitis; Maintenance of healing of erosive esophagiti...
Dosage: TABLET;ORAL
MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM BICARBONATE family patents
2. Zegerid patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7399772 | SANTARUS | Substituted benzimidazole dosage forms and method of using same |
Jul, 2016
(7 years ago) | |
| US6699885 | SANTARUS | Substituted benzimidazole dosage forms and methods of using same |
Jul, 2016
(7 years ago) | |
| US6489346 | SANTARUS | Substituted benzimidazole dosage forms and method of using same |
Jul, 2016
(7 years ago) | |
| US6645988 | SANTARUS | Substituted benzimidazole dosage forms and method of using same |
Jul, 2016
(7 years ago) | |
Drugs and Companies using MAGNESIUM HYDROXIDE; OMEPRAZOLE; SODIUM BICARBONATE ingredient
Market Authorisation Date: 24 March, 2006
Treatment: Short-term treatment of active duodenal ulcer; Treatment of heartburn and other symptoms associated with gerd; Short-term treatment of erosive esophagitis; Maintenance of healing of erosive esophagiti...
Dosage: TABLET, CHEWABLE;ORAL
ZEGERID family patents